Partial response to crizotinib + regorafenib + PD-1 inhibitor in a metastatic BRAF V600EMT colon cancer patient with acquired C-MET amplification and TPM4-ALK fusion: a case report
Article in AME Case Reports (April 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in AME Case Reports (April 2024)
Article in Chinese Clinical Oncology (February 2024)
Article in Cancer Treatment and Research Communications (April 2023)